Andexanet Alfa (Proposed Name: AndexXa)February 13, 2018
Andexanet alfa is an inactive modified recombinant factor Xa molecule that competes with circulating levels of factor Xa to bind directly with factor Xa inhibitors. It is administered intravenously. It was developed for emergency use to reverse the activity of oral factor Xa inhibitors.
If you have a Hayes login, click here to view the full report on the Knowledge Center.